IART Operating Cash Flow (Statement)

Integra Lifesciences Holdings Corp · Operating Cash Flow (Statement)

IART logo

IART Operating Cash Flow (Statement)

Latest reported$85.33M
IART TTM Cash from Operations (-$8.00M → $85.33M)
High-resolution chart · PNG

IART operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Integra Lifesciences Holdings Corp Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
85,327,000
71,444,000
50,384,000
89,308,000
70,887,000
102,369,000
129,382,000
137,392,000
141,677,000
129,555,000
139,955,000
166,539,000
208,082,000
246,280,999
264,468,999
248,411,999
262,877,999
287,690,000
312,427,000
323,412,000
310,272,000
252,098,999
203,831,999
212,753,999
177,871,999
222,763,000
231,433,000
184,937,000
229,431,000
187,636,000
199,683,000
168,544,000
134,535,000
127,193,000
114,544,000
109,524,000
111,049,000
126,116,000
116,405,000
135,268,000
107,850,000
82,035,000
94,483,000
89,848,000
101,574,000
99,828,000
79,463,000
70,402,000
70,135,000
56,676,000
53,268,000
37,784,000
34,885,000
34,243,000
58,715,000
97,198,000
93,084,000
115,391,000
104,328,000
98,063,000
103,914,000
98,689,000
105,571,000
124,185,000
122,905,000
134,185,000
143,235,000
123,282,000
122,044,000
89,431,000
72,590,000
60,092,000
43,636,000
52,090,000
47,026,000
53,367,000
67,136,000
76,113,000
71,702,000
65,729,000
53,685,000
54,486,000
56,848,000
48,879,000
47,590,000
41,358,000
38,975,000
35,648,000
32,613,000
36,849,000
34,826,000
42,658,000
42,777,000
35,270,000
31,985,000
27,162,000
25,013,000
16,693,000
15,701,000
7,564,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.